The illness begins with a relapsing-remitting MS course in 85%???90% of patients; the other 10%???15% have a primary progressive onset MS. Our current understanding is that MS is an autoimmune disorder with an inflammatory T-cell attack on myelin or some component of the oligodendrocyte--myelin structure.